Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma

Condition:   Glioblastoma Intervention:   Drug: Pembrolizumab and Temozolomide Sponsor:   University of Louisville Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials